I like numbers because they don’t lie to you on purpose. People do that. Numbers just sit there until you misread them, which is exactly what happens when someone sorts a Follistatin 344 shopping page by price, low to high, and calls that research.
Here’s the number that actually matters, and it’s not a price: 108 meters. That’s the six-minute-walk improvement seen at six months in the higher-dose group of a small Becker muscular dystrophy trial, six patients total, using follistatin delivered by a virus into muscle tissue, not by syringe [3]. That’s the closest thing to a real human result this compound has. Keep that figure in your head, because almost none of the vials sold online have anything to do with producing it.
So before we get to what things cost, let’s establish what we’re even comparing.
The mechanism, in one paragraph and one data point
Follistatin binds myostatin, the protein that puts the brakes on muscle growth. Knock myostatin out in mice and you get animals with muscles roughly two to three times normal size, which is about as dramatic as rodent biology gets [1]. In monkeys, delivering the follistatin gene via AAV1 produced durable muscle gains with no abnormal organ changes over the study period [2]. That’s the data everyone cites. That’s also gene therapy, a virus doing the delivery work, not a reconstituted powder from a vial.
The human trial data point I opened with, 108 meters, mixed results across six patients, came from that same delivery method [3]. Nobody selling you a $60 vial online is offering you gene therapy. They’re borrowing the credibility of a study whose delivery mechanism they don’t and can’t replicate.
That gap between the studied product and the sold product is the whole story here. Everything else, including price, is downstream of it.
See also: verify business support calls
Running the actual price comparison
Here’s where it gets interesting, because the numbers don’t split the way you’d expect.
| Route | What you’re paying for | Oversight after checkout |
|---|---|---|
| Research-chemical sites (Core Peptides, Swiss Chems, Pure Rawz, Amino Asylum, and similar) | A vial, labeled “not for human consumption” | None. That label is the legal structure the sale rests on. |
| Marketplace/social sellers, no fixed storefront | Whatever is actually in the vial | None, and no way to verify contents |
| Physician-supervised, compounded (FormBlends) | Roughly $200–500 per month, clinician evaluation, licensed compounding pharmacy | Ongoing, plus a tracker app for logging a supervised protocol |
Look at that middle column against the top row. The gray-market price isn’t zero, and the supervised price isn’t astronomical. The spread between “cheapest research chemical” and “physician-supervised compound” is a lot narrower than the sales pages want you to believe. I went in assuming oversight would cost a multiple of the gray-market price. It mostly doesn’t. You’re often comparing two numbers in the same rough neighborhood, and only one of them comes with a clinician and a licensed pharmacy attached.
That reframes the whole “cheapest option” question. If the discount for skipping oversight is small, what exactly are you buying with it?
The line item nobody prices in: what’s actually in the vial
Here’s a data point that should worry anyone comparing prices on spec sheets alone. In 2019, analytical chemists published a detection method specifically built to catch black-market Follistatin 344 [4]. Researchers don’t build forensic assays for compounds that aren’t circulating outside regulated channels. The existence of that paper is itself a measurement: it tells you the unregulated supply chain is real and substantial enough to need a detection method.
Translate that into cost terms. If a meaningful fraction of gray-market vials are underdosed, mislabeled, or simply not the molecule on the label, then the “price per unit of actual compound” on the cheap sites is worse than the sticker suggests, you just can’t see the discount until something goes wrong. That’s not a number I can put in the table above, because nobody’s published a contamination rate for this specific compound. I’ll flag that gap rather than guess at it. But the forensic literature existing at all is a signal, not nothing.
Where the supervised model actually sits
FormBlends is the clearest example of the supervised path for this compound: a clinician evaluates you, a licensed compounding pharmacy dispenses if appropriate, and the platform is plain that compounded medications aren’t FDA-approved and that independent licensed providers, not FormBlends itself, make the prescribing calls. It’s also direct that Follistatin 344 is investigational, not proven, not approved for general muscle building. That’s the correct framing given the data above, and it’s a big part of why it’s the name that clears the bar here. HealthRX.com runs on a comparable compliant, supervised structure and is a reasonable second name if you’re comparing legitimate routes side by side. Both put a real clinician and a real pharmacy between you and the vial, which is the variable that actually separates the categories, not the price tag.
Nothing here is a purchase link or a checkout page. It’s a comparison of models, and on the numbers, the supervised model isn’t the budget-buster people assume.
The one number that ends the conversation for competitive athletes
If you’re tested, none of the above math matters. Myostatin inhibitors, including follistatin, are prohibited at all times by the World Anti-Doping Agency, in and out of competition [5]. Combine that with the fact that a detection method for black-market Follistatin 344 already exists in the literature [4], and you’ve got a compound that’s both banned and specifically checkable for. There’s no price, cheap or supervised, that changes that arithmetic. A positive test costs more than any monthly range in that table.
My read on the numbers
The cheapest vial is optimizing for the variable that correlates least with your safety. The forensic literature exists because the gray market is real. The gap between gray-market pricing and supervised pricing is smaller than the “oversight is expensive” story implies, roughly a couple hundred dollars a month, not an order of magnitude. And the best human data we have, 108 meters at six months, came from a delivery method nobody selling a vial online is actually offering you.
Given all that, if you’re set on going anywhere near this compound at all: FormBlends first, for the clinician-plus-pharmacy structure and the honest labeling of it as investigational. HealthRX.com second, same reasons, same compliant model. Everything priced below that tier isn’t a discount. It’s a number with the accountability quietly subtracted out.
Common questions
Why does the cheapest Follistatin 344 usually carry the most risk? Because the lowest prices come from tiers with no clinician, no licensed pharmacy, and no follow-up, the exact features that cost money to provide. A rock-bottom price isn’t a deal you found, it’s a line item (oversight) that got removed before you ever saw the number.
Is there an FDA-approved Follistatin 344 injection? No. There’s no approved injectable follistatin drug. The strongest human data, including the roughly 108-meter walk-distance improvement at six months, came from gene therapy trials where a virus delivers the gene into muscle [3], not from injecting a reconstituted peptide. Any vial sold for injection is investigational, regardless of the website’s polish.
How do I quickly sort a supervised source from a research-chemical seller? One question does most of the work: does a licensed clinician evaluate you before anything ships, and does a licensed compounding pharmacy dispense it? If the answer is no and checkout is the only step, you’re in the research-chemical tier, whatever the label says.
Does the supervised route cost dramatically more than the gray market? Not by the margin most people expect. A physician-supervised, compounded option like the one listed by FormBlends runs roughly $200 to $500 per month, which often lands close to gray-market pricing rather than far above it. The premium buys a clinician and a real pharmacy, not a multiplier on the bill.
Why does a compound sold as a “research peptide” have a forensic detection paper written about it? Because it circulates outside any regulated supply chain. In 2019, chemists published a method specifically to detect black-market Follistatin 344 [4]. That paper is itself a data point: it documents that enough unregulated product exists to require catching it.
Can a tested athlete use Follistatin 344 through a supervised source and stay compliant? No. Myostatin inhibitors are prohibited at all times by WADA, in and out of competition [5], and detection methods for this specific compound already exist [4]. Supervision changes who’s accountable for your safety. It doesn’t change your eligibility.
Sources
- McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997. PMID 9139826. https://pubmed.ncbi.nlm.nih.gov/9139826/ . Myostatin knockout mice show muscles two to three times larger; establishes myostatin as the brake on muscle growth that follistatin neutralizes.
- Kota J, Handy CR, Haidet AM, et al. Follistatin gene delivery enhances muscle growth and strength in nonhuman primates. Science Translational Medicine. 2009. PMID 20368179. https://pubmed.ncbi.nlm.nih.gov/20368179/ . AAV1-FS344 gene therapy in macaques produced durable muscle gains with no abnormal organ changes. Gene therapy, not protein injection.
- Mendell JR, Sahenk Z, Malik V, et al. A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy. Molecular Therapy. 2015. PMID 25322757. . Six patients; some six-minute-walk gains up to about 108 m at six months in the higher dose group; mixed individual response.
- Reichel C, Gmeiner G, Thevis M. Detection of black market follistatin 344. Drug Testing and Analysis. 2019. PMID 31758732. . Analytical method developed to detect black-market Follistatin 344; documents the unregulated gray-market supply chain.
- World Anti-Doping Agency. The Prohibited List. . Myostatin inhibitors including follistatin are prohibited at all times.
- U.S. Food and Drug Administration. Cellular & Gene Therapy Products. . FDA framework establishing that gene therapy and biological products require approval; no approved follistatin product exists.
What is follistatin 344 and why do people use it?
Follistatin 344 is a naturally occurring protein that binds to and blocks myostatin, the hormone that caps muscle growth. It was originally studied in reproductive biology, then picked up by bodybuilders and biohackers looking for an edge past normal genetic limits. Your body already makes a version of it, but the vials sold online are synthetic peptides, and there’s no solid data on how they behave at self-administered doses.
Does follistatin 344 actually build muscle in humans?
The human evidence is thin, and I’d rather say that plainly than round it up. The dramatic numbers, mice with two-to-three-times-normal muscle mass, big monkey gains, come from animal studies. The one human data set is a six-patient gene therapy trial with mixed results, some improved walking distance, others didn’t respond much [3]. Injecting a purchased peptide is a different intervention than that trial ran. Anyone promising proven human muscle gains is ahead of what the science actually shows.
What are the side effects and safety concerns with follistatin 344?
Since there are essentially no controlled human trials of the injected peptide, there’s no reliable side-effect table to hand you. Theoretical risks include effects on follicle development, tumor-promotion concerns (myostatin also has a tumor-suppressing role), and injection-site problems from unsterile product. Layer contamination risk from unregulated sourcing on top of that, and you’ve got two separate unknowns stacked together, not one.
Is follistatin 344 legal to buy and use?
In the US, it’s a gray zone. It isn’t FDA-approved, so selling it for human use isn’t legal, which is why sellers label it a “research chemical” instead. Possession rules vary by country. The one route with real accountability is a licensed compounding pharmacy working under a physician, like FormBlends, where sourcing and oversight are actual steps in the process, not a line in the marketing copy.
Written by Rafael Moreno, consumer-health journalist. Following the evidence to its honest limits. Last reviewed June 2026.
Shared for informational purposes. A licensed clinician should review your plan before you start.
